AC PACLitaxel Dose Dense Regimen Cycles 1 to 4 (CP-0050) September 2019
|
|
AC PACLitaxel Dose Dense Regimen Cycles 5 to 8 (CP-0051) September 2019
|
|
AC Regimen (CP-0052) June 2018
|
|
AC weekly PACLitaxel dose dense Cycles 1 to 4 Regimen (CP-0367) July 2023
|
|
AC weekly PACLitaxel dose dense Cycles 5 to 8 Regimen (CP-0368) July 2023
|
|
alpelisib fulvestrant Regimen Cycle 1 (CP-0405) September 2023
|
|
alpelisib fulvestrant Regimen Cycles 2 + (CP-0406) September 2023
|
|
Caelyx 30 Regimen (CP-0043) June 2018
|
|
Caelyx 35 Regimen (CP-0044) June 2018
|
|
capecitabine 14 Day Regimen (CP-0047) June 2018
|
|
capecitabine 1500 mg Regimen (CP-0383) August 2023
|
|
capivasertib 400 mg fulvestrant 500 mg Regimen Cycle 1 (CP-0493) October 2024
|
|
capivasertib 400 mg fulvestrant 500 mg Regimen Cycles 2+ (CP-0494) October 2024
|
|
Enhertu (trastuzumab deruxtecan) 5.4 mg/kg Regimen (CP-0283) February 2023
|
|
Enhertu (trasutumab deruxtecan) 5.4 mg/kg Regimen (CP-0362) July 2023
|
|
FEC Regimen (CP-0040) June 2018
|
|
FEC-D (DOCEtaxel Arm) Regimen (CP-0041) October 2019
|
|
FEC-D (FEC Arm) Regimen (CP-0042) October 2019
|
|
Herceptin(trastuzumab) 6 mg/kg Maintenance Regimen (CP-0112) July 2020
|
|
HTCyclo Kanjinti Cycle 1 Regimen (CP-0095) January 2021
|
|
HTCyclo Kanjinti Post Cycle 1 Regimen (CP-0096) January 2021
|
|
Kadcyla Adjuvant Regimen (CP-0155) March 2021
|
|
Kanjinti (trastuzumab) 6 mg/kg tucatinib 300 mg capecitabine 1000 Regimen Post Cycle 1 (CP-0334) May 2023
|
|
Kanjinti (trastuzumab) 8 mg/kg tucatinib 300 mg capecitabine 1000 Regimen Cycle 1 (CP-0333) May 2023
|
|
Kanjinti(trastuzumab) 6 mg/kg Maintenance Regimen (CP-0114) July 2020
|
|
Kanjinti(trastuzumab) 6 mg/kg PACLitaxel 80 Post Cycle 1 Regimen (CP-0183) April 2022
|
|
Kanjinti(trastuzumab) 8 mg/kg PACLitaxel 80 Cycle 1 Regimen (CP-0182) April 2022
|
|
PACLitaxel 80 D1,8,15 q28d Regimen (CP-0435) February 2024
|
|
palbociclib 125 mg tamoxifen 20 mg maintenance Regimen (CP-0508) September 2024
|
|
palbociclib tamoxifen Regimen (CP-0393) August 2023
|
|
pembrolizumab 2 mg/kg nab-PACLItaxel (Abraxane) 100 Regimen (CP-0450) February 2024
|
|
pembrolizumab 2 mg/kg PACLitaxel 80 CARBOplatinAUC1.5 DOXOrubicin 60 cyclophosphamide 600 Regimen Cycles 1-4 (CP-0309) April 2023
|
|
pembrolizumab 2 mg/kg PACLitaxel 80 CARBOplatinAUC1.5 DOXOrubicin 60 cyclophosphamide 600 Regimen Cycles 5-8 (CP-0310) April 2023
|
|
pembrolizumab 200 mg lenvatinib 20 mg Regimen (CP-0285) February 2023
|
|
pembrolizumab 4 mg/kg eTNBC maintenance Regimen (CP-0427 ) January 2024
|
|
pembrolizumab 4 mg/kg Regimen (CP-0514) October 2024
|
|
pembrolizumab 400 mg lenvatinib 20 mg Regimen (CP-0286) February 2023
|
|
Perjeta(PERTuzumab) 420 mg Herceptin(trastuzumab) 6 mg/kg Abraxane(NAB-PACLitaxel) 100 Regimen Post Cycle 1 (CP-0056) June 2020
|
|
Perjeta(PERTuzumab) 420 mg Herceptin(trastuzumab) 6 mg/kg Regimen (CP-0113) July 2020
|
|
Perjeta(PERTuzumab) 420 mg Kanjinti(trastuzumab) 6 mg/kg Abraxane (nab-PACLitaxel) Regimen POST CYCLE 1 Jun 2022 (CP-0206)
|
|
Perjeta(PERTuzumab) 420 mg Kanjinti(trastuzumab) 6 mg/kg Maintenance Regimen Jun 2022 (CP-0204)
|
|
Perjeta(PERTuzumab) 420 mg Kanjinti(trastuzumab) 6 mg/kg Maintenance Reload Post Cycle 1 Regimen Jun 2022 (CP-0208)
|
|
Perjeta(PERTuzumab) 840 mg Herceptin(trastuzumab) 8 mg/kg Abraxane(NAB-PACLitaxel) 100 Regimen Cycle 1 (CP-0055) June 2020
|
|
Perjeta(PERTuzumab) 840 mg Kanjinti(trastuzumab) 8 mg/kg Abraxane (nab-PACLitaxel) Regimen CYCLE 1 Jun 2022 (CP-0205)
|
|
Perjeta(PERTuzumab) 840 mg Kanjinti(trastuzumab) 8 mg/kg Maintenance Reload Cycle 1 Regimen Jun 2022 (CP-0207)
|
|
ribociclib 600 mg anastrozole 1 mg Regimen (CP-0322) May 2023
|
|
ribociclib 600 mg exemestane 25 mg Regimen (CP-0321) May 2023
|
|
sacituzumab govitecan 10 mg/kg Regimen (CP-0360) June 2023
|
|
TAC Regimen (CP-0060) October 2019
|
|
TC Regimen (CP-0046) January 2021
|
|
TCarboH Kanjinti (CP-0097) January 2021
|
|
TCarboH Kanjinti Regimen (CP-0098) January 2021
|
